# Trial to Evaluate the Ability of a Single Infusion of High-Density Lipoprotein (HDL) to Modulate Markers of Cerebral Ischaemia

> **NCT00822302** · NA · COMPLETED · sponsor: **St George's, University of London** · enrollment: 40 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Reconstituted High Density Lipoprotein
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT00822302
- **Lead sponsor:** St George's, University of London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-12
- **Final completion:** 2009-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00822302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00822302, "Trial to Evaluate the Ability of a Single Infusion of High-Density Lipoprotein (HDL) to Modulate Markers of Cerebral Ischaemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00822302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*